Elizabeth A. Sugar
- Otorhinolaryngology top 0.2%
- Head and Neck Cancer Studies 11
- Ophthalmology top 0.5%
- Ocular Diseases and Behçet’s Syndrome 23
- Retinal and Optic Conditions 16
- Retinal Diseases and Treatments 14
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research 25
- Cancer Immunotherapy and Biomarkers 15
- Periodontics top 1%
- Immunology top 2%
-
- Asthma and respiratory diseases 15
-
- Cervical Cancer and HPV Research 10
- Co-authors
- Gypsyamber DʼSouzaMaura L. GillisonRaphael P. ViscidiWeihong XiaoWilliam H. WestraShahnaz BegumJanet T. HolbrookDouglas A. Jabs
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Elizabeth A. Sugar
110 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Otorhinolaryngology 1.4k
- Ophthalmology 958
- Oncology 2.5k
- Periodontics 307
- Immunology 1.1k
Countries citing papers authored by Elizabeth A. Sugar
This map shows the geographic impact of Elizabeth A. Sugar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth A. Sugar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth A. Sugar more than expected).
Fields of papers citing papers by Elizabeth A. Sugar
This network shows the impact of papers produced by Elizabeth A. Sugar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth A. Sugar. The network helps show where Elizabeth A. Sugar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth A. Sugar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 14 | |
| 6 | 2020 | 91 | |
| 7 | 2020 | 7 | |
| 8 | 2018 | 26 | |
| 9 | 2016 | 96 | |
| 10 | 2016 | 16 | |
| 11 | 2015 | 65 | |
| 12 | 2015 | 21 | |
| 13 | 2014 | 11 | |
| 14 | 2013 | 24 | |
| 15 | 2011 | 295 | |
| 16 | 2009 | 40 | |
| 17 | 2009 | 83 | |
| 18 | 2008 | 259 | |
| 19 | 2008 | 162 | |
| 20 | 2006 | 26 |
About Elizabeth A. Sugar
Elizabeth A. Sugar is a scholar working on Otorhinolaryngology, Ophthalmology and Oncology, having authored 113 papers that have together received 6.2k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (25 papers), Ocular Diseases and Behçet’s Syndrome (23 papers), Retinal and Optic Conditions (16 papers), Cancer Immunotherapy and Biomarkers (15 papers), Asthma and respiratory diseases (15 papers), Retinal Diseases and Treatments (14 papers), Head and Neck Cancer Studies (11 papers) and Cervical Cancer and HPV Research (10 papers). The work is most often cited by research in Otorhinolaryngology (1.4k citations), Ophthalmology (958 citations) and Oncology (2.5k citations). Elizabeth A. Sugar has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Gypsyamber DʼSouza, Maura L. Gillison, Raphael P. Viscidi, Weihong Xiao, William H. Westra, Shahnaz Begum, Janet T. Holbrook, Douglas A. Jabs, Elizabeth M. Jaffee and Michael M. Altaweel. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.